Corrigendum to “Oral minocycline therapy as first-line treatment in patients with Myalgic encephalomyelitis and long COVID: A pilot study” [eNeurologicalSci 38 (2025) 100537].

Kunihisa Miwa

Open source

DOI
10.1016/j.ensci.2025.100557
Published
2025-03
Container
eNeurologicalSci
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ensci.2025.100557,
  title = {Corrigendum to “Oral minocycline therapy as first-line treatment in patients with Myalgic encephalomyelitis and long COVID: A pilot study” [eNeurologicalSci 38 (2025) 100537].},
  author = {Kunihisa Miwa},
  year = {2025},
  journal = {eNeurologicalSci},
  doi = {10.1016/j.ensci.2025.100557},
  url = {https://doi.org/10.1016/j.ensci.2025.100557}
}

RIS

TY  - JOUR
TI  - Corrigendum to “Oral minocycline therapy as first-line treatment in patients with Myalgic encephalomyelitis and long COVID: A pilot study” [eNeurologicalSci 38 (2025) 100537].
AU  - Kunihisa Miwa
PY  - 2025
JO  - eNeurologicalSci
DO  - 10.1016/j.ensci.2025.100557
UR  - https://doi.org/10.1016/j.ensci.2025.100557
ER  - 

APA

Miwa, K. (2025). Corrigendum to “Oral minocycline therapy as first-line treatment in patients with Myalgic encephalomyelitis and long COVID: A pilot study” [eNeurologicalSci 38 (2025) 100537].. eNeurologicalSci. https://doi.org/10.1016/j.ensci.2025.100557

Source records